Pasar al contenido principal

PAPEL DE LA GALECTINA-3 EN LA RESPUESTA INMUNE ASOCIADA A ENFERMEDADES DEL SISTEMA NERVIOSO CENTRAL. IMPLICACION EN ENFERMEDADES NEURODEGENERATIVAS Y GLIOBLASTOMA MULTIFORME.

RTI2018-098645-B-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos I+D+i Retos de Investigación
Año convocatoria 2018
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD DE SEVILLA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 8
Encontrada(s) 1 página(s)

RODIN. Repositorio de Objetos de Docencia e Investigación de la Universidad de Cádiz
Publicación Artículo científico (JournalArticle)

The Absence of Caspase-8 in the Dopaminergic System Leads to Mild Autism-like Behavior

  • Suárez-Pereira, Irene
  • García Domínguez, I.
  • Bravo García, Lidia
  • Santiago, M.
  • García-Revilla, J.
  • Espinosa-Oliva, A.M.
  • Alonso-Bellido, I.M.
  • López Martín, Carolina
  • Pérez-Villegas, E.M.
  • Armengol, J.A.
  • Berrocoso Domínguez, Esther María
  • Venero, J.L.
  • de Pablos, R.M.
  • Ruiz, R.
In the last decade, new non-apoptotic roles have been ascribed to apoptotic caspases. This family of proteins plays an important role in the sculpting of the brain in the early stages of development by eliminating excessive and nonfunctional synapses and extra cells. Consequently, impairments in this process can underlie many neurological and mental illnesses. This view is particularly relevant to dopamine because it plays a pleiotropic role in motor control, motivation, and reward processing. In this study, we analyze the effects of the elimination of caspase-8 (CASP8) on the development of catecholaminergic neurons using neurochemical, ultrastructural, and behavioral tests. To do this, we selectively delete the CASP8 gene in cells that express tyrosine hydroxylase with the help of recombination through the Cre-loxP system. Our results show that the number of dopaminergic neurons increases in the substantia nigra. In the striatum, the basal extracellular level of dopamine and potassium-evoked dopamine release decreased significantly in mice lacking CASP8, clearly showing the low dopamine functioning in tissues innervated by this neurotransmitter. This view is supported by electron microscopy analysis of striatal synapses. Interestingly, behavioral analysis demonstrates that mice lacking CASP8 show changes reminiscent of autism spectrum disorders (ASD). Our research reactivates the possible role of dopamine transmission in the pathogenesis of ASD and provides a mild model of autism.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Selective deletion of Caspase-3 gene in the dopaminergic system exhibits autistic-like behaviour

  • García-Domínguez, Irene
  • Suárez-Pereira, Irene
  • Santiago, Marti
  • Pérez-Villegas, Eva María
  • Bravo, Lidia
  • López-Martín, Carolina
  • Roca-Ceballos, María Angustias
  • García-Revilla, Juan
  • Espinosa-Oliva, Ana M.
  • Rodríguez-Gómez, José A.
  • Joseph, Bertrand
  • Berrocoso, Esther
  • Armengol, José Ángel
  • Venero, José L.
  • Ruiz, Rocío
  • Pablos, Rocío M. de
Apoptotic caspases are thought to play critical roles in elimination of excessive and non-functional synapses and removal of extra cells during early developmental stages. Hence, an impairment of this process may thus constitute a basis for numerous neurological and psychiatric diseases. This view is especially relevant for dopamine due to its pleiotropic roles in motor control, motivation and reward processing. Here, we have analysed the effect of caspase-3 depletion on the development of catecholaminergic neurons and performed a wide array of neurochemical, ultrastructural and behavioural assays. To achieve this, we performed selective deletion of the Casp3 gene in tyrosine hydroxylase (TH)-expressing cells using Cre-loxP-mediated recombination. Histological evaluation of most relevant catecholaminergic nuclei revealed the ventral mesencephalon as the most affected region. Stereological analysis demonstrated an increase in the number of TH-positive neurons in both the substantia nigra and ventral tegmental area along with enlarged volume of the ventral midbrain. Analysis of main innervating tissues revealed a rather contrasting profile. In striatum, basal extracellular levels and potassium-evoked DA release were significantly reduced in mice lacking Casp3, a clear indication of dopaminergic hypofunction in dopaminergic innervating tissues. This view was sustained by analysis of TH-labelled dopaminergic terminals by confocal and electron microscopy. Remarkably, at a behavioural level, Casp3-deficient mice exhibited impaired social interaction, restrictive interests and repetitive stereotypies, which are considered the core symptoms of autism spectrum disorder (ASD). Our study revitalizes the potential involvement of dopaminergic transmission in ASD and provides an excellent model to get further insights in ASD pathogenesis., This work was supported by grants from the Spanish Ministerio de Economía y Competitividad (SAF2015-64171-R and RTI2018-098645-B-I00). J.A.A. and E.P.V. was supported by a MINECO (BFU2015-64536) grant. I.S.P., E.B. and L.B. were co-financed by the “Fondo Europeo de Desarrollo Regional” (FEDER)-UE “A way to build Europe” from the “Ministerio de Ciencia, Innovación y Universidades” (RTI2018-099778-B-I00) and the Ministerio de Salud-Instituto de Salud Carlos III (PI18/01691), as well as funding from the “Consejería de Salud de la Junta de Andalucía” (PI-0134-2018); the “Programa Operativo de Andalucía FEDER, Iniciativa Territorial Integrada ITI 2014-2020 Consejería Salud, Junta de Andalucía” (PI-0080-2017); the “Consejería de Economía, Innovación, Ciencia y Empleo de la Junta de Andalucía” (CTS-510); and the “Centro de Investigación Biomédica en Red de Salud Mental- CIBERSAM” (CB/07/09/0033).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Arginine deprivation alters microglial polarity and synergizes with radiation to eradicate non-arginine-auxotrophic glioblastoma tumors

  • Hajji, Nabil
  • García-Revilla, Juan
  • Sarmiento, Manuel
  • Perryman, Richard
  • Symington, Jake
  • Quarles, Chad C.
  • Healey, Deborah R.
  • Guo, Yijie
  • Orta-Vázquez, Manuel Luis
  • Mateos-Cordero, Santiago
  • Shah, Khalid
  • Bomalaski, John
  • Anichini, Giulio
  • Tzakos, Andreas G
  • Crook, Timothy
  • O'Neill, Kevin
  • Scheck, Adrienne C.
  • Venero, José L.
  • Syed, Nelofer
New approaches for the management of glioblastoma (GBM) are an urgent and unmet clinical need. Here, we illustrate that the efficacy of radiotherapy for GBM is strikingly potentiated by concomitant therapy with the arginine-depleting agent ADI-PEG20 in a non-arginine-auxotrophic cellular background (argininosuccinate synthetase 1 positive). Moreover, this combination led to durable and complete radiological and pathological response, with extended disease-free survival in an orthotopic immune-competent model of GBM, with no significant toxicity. ADI-PEG20 not only enhanced the cellular sensitivity of argininosuccinate synthetase 1-positive GBM to ionizing radiation by elevated production of nitric oxide (˙NO) and hence generation of cytotoxic peroxynitrites, but also promoted glioma-associated macrophage/microglial infiltration into tumors and turned their classical antiinflammatory (protumor) phenotype into a proinflammatory (antitumor) phenotype. Our results provide an effective, well-tolerated, and simple strategy to improve GBM treatment that merits consideration for early evaluation in clinical trials., This work was supported by the Brain Tumour Research Campaign (BTRC), Brain Tumour Research (BTR) CRUK Convergence Science Centre at The Institute of Cancer Research, London, and Imperial College London (C309/A31316) and the European Regional Development Fund (ERDF) under the Operational Program Epirus 2014-2020, NSRF 2014-2020 (project code 5033092, BIOPREDICTOR) and by the Hellenic Foundation for Research and Innovation (HFRI) under the “First call for HFRI research projects to support faculty members and researchers and the procurement of high-cost research equipment grant” (project code: 991, PROTECT). This research was also funded from grants by the Spanish Ministerio de Ciencia, Innovación y Universidades/FEDER/UE RTI2018-098645-B-100) and from Consejería de Economía y Conocimiento of Junta de Andalucía/FEDER/UE P18-RT-1372 and US-1264806. BTRC and BTR grants were awarded to NS and KON. JS was a recipient of CRUK Clinical Academic Training Programme. ADI-PEG20 was a gift from Polaris Pharmaceuticals Inc., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Gal3 Plays a Deleterious Role in a Mouse Model of Endotoxemia

  • Fernández-Martín, Juan Carlos
  • Espinosa-Oliva, Ana M.
  • García-Domínguez, Irene
  • Rosado-Sánchez, Isaac
  • Pacheco, Yolanda M.
  • Moyano, Rosario
  • García Monterde, José
  • Venero, José L.
  • Pablos, Rocío M. de
Lipopolysaccharide (LPS)-induced endotoxemia induces an acute systemic inflammatory response that mimics some important features of sepsis, the disease with the highest mortality rate worldwide. In this work, we have analyzed a murine model of endotoxemia based on a single intraperitoneal injection of 5 mg/kg of LPS. We took advantage of galectin-3 (Gal3) knockout mice and found that the absence of Gal3 decreased the mortality rate oflethal endotoxemia in the first 80 h after the administration of LPS, along with a reduction in the tissular damage in several organs measured by electron microscopy. Using flow cytometry, we demonstrated that, in control conditions, peripheral immune cells, especially monocytes, exhibited high levels of Gal3, which were early depleted in response to LPS injection, thus suggesting Gal3 release under endotoxemia conditions. However, serum levels of Gal3 early decreased in response to LPS challenge (1 h), an indication that Gal3 may be extravasated to peripheral organs. Indeed, analysis of Gal3 in peripheral organs revealed a robust up-regulation of Gal3 36 h after LPS injection. Taken together, these results demonstrate the important role that Gal3 could play in the development of systemic inflammation, a well-established feature of sepsis, thus opening new and promising therapeutic options for these harmful conditions., This research was funded by grants by the Spanish Ministerio de Ciencia, Innovación y Universidades/FEDER/UE RTI2018-098645-B-100), Junta de Andalucía (Consejería de Economía y Conocimiento, US-1264806) and FIS (PI18/01216). YMP was supported by the Consejería de Salud y Bienestar Social of Junta de Andalucía through the ‘‘NicolásMonardes’’ programme [C-0013-2017]., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Galectin-3 is elevated in CSF and is associated with Aβ deposits and tau aggregates in brain tissue in Alzheimer's disease

  • Boza-Serrano, Antonio
  • Vrillon, Agathe
  • Minta, Karolina
  • Paulus, Agnes
  • Camprubí-Ferrer, Lluís
  • García, Megg
  • Andreasson, Ulf
  • Antonell, Anna
  • Wennström, Malin
  • Gouras, Gunnar K.
  • Dumurgier, Julien
  • Cognat, Emmanuel
  • Molina-Porcel, Laura
  • Balasa, Mircea
  • Vitorica, Javier
  • Sánchez-Valle, Raquel
  • Paquet, Claire
  • Venero, José L.
  • Blennow, Kaj
  • Deierborg, Tomas
Galectin-3 (Gal-3) is a beta-galactosidase binding protein involved in microglial activation in the central nervous system (CNS). We previously demonstrated the crucial deleterious role of Gal-3 in microglial activation in Alzheimer's disease (AD). Under AD conditions, Gal-3 is primarily expressed by microglial cells clustered around Aβ plaques in both human and mouse brain, and knocking out Gal-3 reduces AD pathology in AD-model mice. To further unravel the importance of Gal-3-associated inflammation in AD, we aimed to investigate the Gal-3 inflammatory response in the AD continuum. First, we measured Gal-3 levels in neocortical and hippocampal tissue from early-onset AD patients, including genetic and sporadic cases. We found that Gal-3 levels were significantly higher in both cortex and hippocampus in AD subjects. Immunohistochemistry revealed that Gal-3+ microglial cells were associated with amyloid plaques of a larger size and more irregular shape and with neurons containing tau-inclusions. We then analyzed the levels of Gal-3 in cerebrospinal fluid (CSF) from AD patients (n = 119) compared to control individuals (n = 36). CSF Gal-3 levels were elevated in AD patients compared to controls and more strongly correlated with tau (p-Tau181 and t-tau) and synaptic markers (GAP-43 and neurogranin) than with amyloid-β. Lastly, principal component analysis (PCA) of AD biomarkers revealed that CSF Gal-3 clustered and associated with other CSF neuroinflammatory markers, including sTREM-2, GFAP, and YKL-40. This neuroinflammatory component was more highly expressed in the CSF from amyloid-β positive (A+), CSF p-Tau181 positive (T+), and biomarker neurodegeneration positive/negative (N+/-) (A + T + N+/-) groups compared to the A + T-N- group. Overall, Gal-3 stands out as a key pathological biomarker of AD pathology that is measurable in CSF and, therefore, a potential target for disease-modifying therapies involving the neuroinflammatory response., Open access funding provided by Lund University. Vetenskapsrådet, 2019-0633, Antonio Boza Serrano, Ministerio de Ciencia, Innovación y Universidades, RTI2018-098645-B-100, Jose Luis Venero, PID2021-124096OB-100, Jose Luis Venero, Instituto de Salud Carlos III, 20/00448, Raquel Sanchez-Valle, Union PI18/01556, Javier Vitorica, PI21/00914, Javier Vitorica, Consejería de Economía, Innovación, Ciencia y Empleo, Junta de Andalucía, P18-RT-1372, Jose Luis Venero, US-1262734, Javier Vitorica, Kungliga Fysiografiska Sällskapet i Lund, 20191114ABS, Antonio Boza Serrano, 20211129ABS, Antonio Boza Serrano, Greta och Johan Kocks stiftelser, 20201201ABS, Antonio Boza Serrano, Consejería de Economía, Conocimiento, E mpresas y Universidad, Junta de Andalucía, US-1264806, Jose Luis Venero, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Galectin-3, a rising star in modulating microglia activation under conditions of neurodegeneration

  • García-Revilla, Juan
  • Boza-Serrano, Antonio
  • Espinosa-Oliva, Ana M.
  • Sarmiento, Manuel
  • Deierborg, Tomas
  • Ruiz, Rocío
  • Martínez de Pablos, Rocío
  • Burguillos, Miguel Ángel
  • Venero, José L.
The advent of high-throughput single-cell transcriptomic analysis of microglia has revealed different phenotypes that are inherently associated with disease conditions. A common feature of some of these activated phenotypes is the upregulation of galectin-3. Representative examples of these phenotypes include disease-associated microglia (DAM) and white-associated microglia (WAM), whose role(s) in neuroprotection/neurotoxicity is a matter of high interest in the microglia community. In this review, we summarise the main findings that demonstrate the ability of galectin-3 to interact with key pattern recognition receptors, including, among others, TLR4 and TREM2 and the importance of galectin-3 in the regulation of microglia activation. Finally, we discuss increasing evidence supporting the involvement of this lectin in the main neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis, multiple sclerosis, traumatic brain injury, and stroke., We thank the Spanish Ministerio de Ciencia, Innovación y Universidades/FEDER/UE RTI2018-098645-B-100, PID2019-107948RA-I00 and RYC-2017-21804; the Agencia Española de Investigación PID2021-124096OB-I00 and PID2021-126090OA-I00; the Spanish Junta de Andalucia /FEDER/EU P18-RT-1372 and the Spanish FEDER I + D + i-USE US-1264806, US-1264152 and US-1265062 from University of Seville. This work has also been supported by the Strategic Research Area MultiPark (Multidisciplinary Research focused on neurodegenerative diseases) at Lund University, the Swedish Alzheimer foundation, the Swedish Brain Foundation, the Crafoord Foundation, the Swedish Dementia Association, the G&J Kock Foundation, the Olle Engkvist Foundation, the Swedish Research Council (Project 2019-06333), the Royal Physiographic Society (42222 and 40594), the A.E. Berger Foundation, the Swedish Parkinson Foundation and the Medical Faculty at Lund University. Open access funding provided by Lund University., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The Absence of Caspase-8 in the Dopaminergic System Leads to Mild Autism-like Behavior

  • Suárez-Pereira, Irene
  • García-Domínguez, Irene
  • Bravo, Lidia
  • Santiago, Marti
  • García-Revilla, Juan
  • Espinosa-Oliva, Ana M.
  • Alonso-Bellido, Isabel María
  • López-Martín, Carolina
  • Pérez-Villegas, Eva María
  • Armengol, José Ángel
  • Berrocoso, Esther
  • Venero, José L.
  • Pablos, Rocío M. de
  • Ruiz, Rocío
In the last decade, new non-apoptotic roles have been ascribed to apoptotic caspases. This family of proteins plays an important role in the sculpting of the brain in the early stages of development by eliminating excessive and nonfunctional synapses and extra cells. Consequently, impairments in this process can underlie many neurological and mental illnesses. This view is particularly relevant to dopamine because it plays a pleiotropic role in motor control, motivation, and reward processing. In this study, we analyze the effects of the elimination of caspase-8 (CASP8) on the development of catecholaminergic neurons using neurochemical, ultrastructural, and behavioral tests. To do this, we selectively delete the CASP8 gene in cells that express tyrosine hydroxylase with the help of recombination through the Cre-loxP system. Our results show that the number of dopaminergic neurons increases in the substantia nigra. In the striatum, the basal extracellular level of dopamine and potassium-evoked dopamine release decreased significantly in mice lacking CASP8, clearly showing the low dopamine functioning in tissues innervated by this neurotransmitter. This view is supported by electron microscopy analysis of striatal synapses. Interestingly, behavioral analysis demonstrates that mice lacking CASP8 show changes reminiscent of autism spectrum disorders (ASD). Our research reactivates the possible role of dopamine transmission in the pathogenesis of ASD and provides a mild model of autism., This work was supported by grants from the Spanish Ministerio de Economía y Competitividad (RTI2018-098645-B-I00), and the Junta de Andalucía (Consejería de Economía y Conocimiento; P18-RT-1372 and US-1264806). JA and EP-V were supported by a MINECO (PID2019-109569GB-I00) grant. IS-P, LB, CL-M, and EB were supported by the “Fondo Europeo de Desarrollo Regional” (FEDER)-UE “A way to build Europe” from the “Ministerio de Economía y Competitividad” (RTI2018-099778-B-I00); from the “Plan Nacional sobre Drogas, Ministerio de Sanidad, Consumo y Bienestar Social” (2019I041); from “Ministerio de Salud-Instituto de Salud Carlos III (PI18/01691); from the “Programa Operativo de Andalucía FEDER, Iniciativa Territorial Integrada ITI 2014-2020 Consejería Salud y Familias, Junta de Andalucía” (PI-0080-2017, PI-0009-2017), "Consejería de Salud y Familias, Junta de Andalucía" (PI-0134-2018 and PEMP-0008-2020); from the "Consejería de Transformación Económica, Industria, Conocimiento y Universidad, Junta de Andalucía" (P20_00958 and CTS-510); from the CEIMAR (CEIJ-003); from the “Instituto de Investigación e Innovación en Ciencias Biomédicas de Cádiz-INiBICA” (LI19/06IN-CO22; IN-C09); from the “CIBERSAM” (CB07/09/0033) and from the European Union’s Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 955684. Images were obtained in the Centro de Investigación, Tecnología e Innovación de la Universidad de Sevilla (CITIUS)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

TET2 Regulates the Neuroinflammatory Response in Microglia

  • Carrillo-Jiménez, Alejandro
  • Deniz, Özgen
  • Niklison-Chirou, Maria Victoria
  • Ruiz, Rocío
  • Bezerra-Salomão, Karina
  • Stratoulias, Vassilis
  • Amouroux, Rachel
  • Yip, Ping Kei
  • Vilalta, Anna
  • Cheray, Mathilde
  • Scott-Egerton, Alexander Michael
  • Rivas Infante, Eloy
  • Tayara, Khadija
  • García-Domínguez, Irene
  • García-Revilla, Juan
  • Fernández-Martín, Juan Carlos
  • Espinosa-Oliva, Ana M.
  • Shen, Xianli
  • St George-Hyslop, Peter
  • Brown, Guy Charles
  • Hajkova, Petra
  • Joseph, Bertrand
  • Venero, José L.
  • Branco, Miguel R.
  • Burguillos, Miguel Ángel
Epigenomic mechanisms regulate distinct aspects of the inflammatory response in immune cells. Despite the central role for microglia in neuroinflammation and neurodegeneration, little is known about their epigenomic regulation of the inflammatory response. Here, we show that Ten-eleven translocation 2 (TET2) methylcytosine dioxygenase expression is increased in microglia upon stimulation with various inflammogens through a NF-κB-dependent pathway. We found that TET2 regulates early gene transcriptional changes, leading to early metabolic alterations, as well as a later inflammatory response independently of its enzymatic activity. We further show that TET2 regulates the proinflammatory response in microglia of mice intraperitoneally injected with LPS. We observed that microglia associated with amyloid β plaques expressed TET2 in brain tissue from individuals with Alzheimer's disease (AD) and in 5xFAD mice. Collectively, our findings show that TET2 plays an important role in the microglial inflammatory response and suggest TET2 as a potential target to combat neurodegenerative brain disorders., A.C.-J. is supported by a pre-doctoral fellowship from the Spanish Ministerio de Educación, Cultura y Deporte. Ö.D. has received funding from the People Programme (Marie Curie Actions) of the European Union’s Seventh Framework Programme (FP7/2007-2013) under REA grant agreement 608765. M.V.N.-C. received a Children with Cancer UK fellowship (14-178). This work was supported by grants from Blizard Research Theme grants Queen Mary University of London; Blizard Institute; Spanish Ministerio de Ciencia, Innovación y Universidades/FEDER/UE RTI2018-098645-B-100; Swedish Research Council; ERA-NET TracInflam; Swedish Brain Foundation; and Karolinska Institutet Foundations. M.R.B. is a Sir Henry Dale Fellow (101225/Z/13/Z), jointly funded by the Wellcome Trust and the Royal Society. M.A.B. has been funded by the Barts Charity Centre for Trauma Sciences (C4TS), the Wellcome Trust Institutional Strategic Support Fund (ISSF), and the Spanish Ministry of Economy and Competitivity (Programa Ramón y Cajal: RYC-2017-21804)., Peer reviewed